EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial

Ana Cardoso iD, Malwina Naghibi, Eric Climent iD, Andrea Rodenes-Gavidia iD, Araceli Lamelas iD, Laura Llobregat, Juan Martínez-Blanch iD, Daniel Friedman iD, Vineetha Vijayakumar iD, Richard Day iD

Allergy · 2026-11 · 81 (11) · 3907-3919

DOI: 10.1111/all.70360 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Allergy, online erschienen am 28.04.2026. Verfasst von Ana Cardoso und 9 weiteren Autor:innen. Beteiligte Einrichtung: R&D Medical Department, ADM Health & Wellness, London, UK. Hauptthemen laut MEDLINE: Bifidobacterium longum, Probiotics, Rhinitis, Allergic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Archer Daniels Midland, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic rhinitis (AR) is an increasingly common chronic inflammatory condition of the nasal mucosa. While conventional anti‐allergy treatments are widely used, they can come with side effects and are not always effective. As a result, AR remains a significant concern for many millions of people worldwide, affecting quality of life and social functioning.

Objective

To investigate clinical evidence for the role of probiotics and postbiotics in reducing AR symptoms.

Methods

In this single‐centre, randomized, double‐blind, placebo‐controlled clinical trial, 72 adults aged 18–60 years with moderate–severe AR, taking first‐line medication, were studied. The primary outcome of the trial was to determine the effects of supplementation with the probiotic Bifidobacterium longum CECT 7347 (PRO) and the heat‐treated postbiotic of the same strain (POST) on symptoms associated with AR as assessed using the Combined Symptom and Medication Score (CSMS). The secondary outcomes of the study assessed the effects of the interventions over: quality of life (rhinitis quality of life questionnaire [RQLQ]), systemic immune response, local immune response, and faecal microbiota composition.

Results

Statistically significant reduction in total CSMS after 8 weeks of supplementation was observed in the POST group compared to placebo control (CON) ( p = 0.022), showing on average a 0.6 greater reduction than placebo (CI: 0.09–1.12), equivalent to a 33.15% greater reduction and exceeding the World Allergy Organization's threshold for minimal clinically significant efficacy.

Conclusion

POST intake for 8 weeks was associated with a statistically significant reduction of total CSMS compared to placebo. There was also improvement in RQLQ parameters when compared to baseline. PRO intake for 8 weeks resulted in non‐significant beneficial effects on AR‐related symptoms. Trial Registration ClinicalTrials.gov Identifier: NCT05208528

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bifidobacterium longumProbioticsRhinitis, AllergicAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultDouble-Blind MethodHot TemperatureQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

allergic rhinitisgut‐respiratory axismicrobiomepostbioticsprobiotics

Autor:innen und Institutionen

  • R&D Medical Department, ADM Health & Wellness, London, UK.
  • ADM, R&D Biopolis, University of Valencia Science Park (Parc Científic de la Universitat de València), Valencia, Spain.

ORCID-Profile: Ana Cardoso, Eric Climent, Andrea Rodenes-Gavidia, Araceli Lamelas, Juan Martínez-Blanch, Daniel Friedman, Vineetha Vijayakumar, Richard Day

Förderung

  • Archer Daniels Midland
  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Cardoso, A., Naghibi, M., Climent, E., Rodenes-Gavidia, A., Lamelas, A., Llobregat, L., Martínez-Blanch, J., Friedman, D., Vijayakumar, V., & Day, R. (2026). Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial. Allergy, 81(11), 3907-3919. https://doi.org/10.1111/all.70360

Vancouver

Cardoso A, Naghibi M, Climent E, Rodenes-Gavidia A, Lamelas A, Llobregat L, et al. Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial. Allergy. 2026;81(11):3907-3919. doi:10.1111/all.70360

BibTeX
@article{Cardoso2026,
  author = {Cardoso, Ana and Naghibi, Malwina and Climent, Eric and Rodenes-Gavidia, Andrea and Lamelas, Araceli and Llobregat, Laura and Martínez-Blanch, Juan and Friedman, Daniel and Vijayakumar, Vineetha and Day, Richard},
  title = {Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {11},
  pages = {3907--3919},
  doi = {10.1111/all.70360}
}
Kostenlos starten →